UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunology and Immunotherapy of Head and Neck Cancer

Journal of clinical oncology, 2015-10, Vol.33 (29), p.3293-3304

Ferris, Robert L

2015

Volltextzugriff (PDF)

The changing therapeutic landscape of head and neck cancer

Nature reviews. Clinical oncology, 2019-11, Vol.16 (11), p.669-683

2019

Volltextzugriff (PDF)

Immunotherapy for head and neck cancer: Recent advances and future directions

Oral oncology, 2019-12, Vol.99, p.104460-104460, Article 104460

2019

Volltextzugriff (PDF)

Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials

Journal of clinical oncology, 2015-10, Vol.33 (29), p.3285-3292

2015

Volltextzugriff (PDF)

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Current oncology reports, 2018-02, Vol.20 (2), p.22-7, Article 22

2018

Volltextzugriff (PDF)

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

Immunity (Cambridge, Mass.), 2020-01, Vol.52 (1), p.183-199.e9

2020

Volltextzugriff (PDF)

Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules

Cancer, 2018-04, Vol.124 (8), p.1682-1690

2018

Volltextzugriff (PDF)

Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma

European journal of cancer (1990), 2017-05, Vol.76, p.152-166

2017

Volltextzugriff (PDF)

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

Journal of clinical oncology, 2022-01, Vol.40 (2), p.138-149

2022

Volltextzugriff (PDF)

Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape

Journal of clinical oncology, 2010-10, Vol.28 (28), p.4390-4399

2010

Volltextzugriff (PDF)

Head and neck cancer

The Lancet (British edition), 2008-05, Vol.371 (9625), p.1695-1709

2008

Volltextzugriff (PDF)

Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

Oncoimmunology, 2017-01, Vol.6 (1), p.e1261779-e1261779

2017

Volltextzugriff (PDF)

TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action

International journal of molecular sciences, 2017-03, Vol.18 (3), p.645-645

2017

Volltextzugriff (PDF)

Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation

Cancer treatment reviews, 2018-02, Vol.63, p.48-60

2018

Volltextzugriff (PDF)

Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Stage I to II Oral Cavity Cancer

The Laryngoscope, 2019-01, Vol.129 (1), p.162-169

2019

Volltextzugriff (PDF)

PD-L1 Mediates Dysfunction in Activated PD-1 + NK Cells in Head and Neck Cancer Patients

Cancer immunology research, 2018-12, Vol.6 (12), p.1548-1560

2018

Volltextzugriff (PDF)

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

Nature communications, 2021-06, Vol.12 (1), p.3349-3349, Article 3349

2021

Volltextzugriff (PDF)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.184-184, Article 184

2019

Volltextzugriff (PDF)

Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients

Clinical cancer research, 2016-11, Vol.22 (21), p.5229-5237

2016

Volltextzugriff (PDF)

HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING

The Journal of clinical investigation, 2020-04, Vol.130 (4), p.1635-1652

2020

Volltextzugriff (PDF)

Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing

Nature communications, 2021-12, Vol.12 (1), p.7338-7338, Article 7338

2021

Volltextzugriff (PDF)

Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT

Oncoimmunology, 2019-07, Vol.8 (7), p.1593805

2019

Volltextzugriff (PDF)

American Thyroid Association statement on preoperative imaging for thyroid cancer surgery

Thyroid (New York, N.Y.), 2015-01, Vol.25 (1), p.3-14

2015

Volltextzugriff (PDF)

Rising incidence of oral tongue cancer among white men and women in the United States, 1973–2012

Oral oncology, 2017-04, Vol.67, p.146-152

2017

Volltextzugriff (PDF)

1 – 25 von 774

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(694)
Mit Volltextzugriff
(686)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(457)
Life Sciences & Biomedicine
(441)
Humans
(393)
Oncology
(238)
Otorhinolaryngology
(194)
Male
(182)
Female
(176)
Middle Aged
(157)
Tumors
(133)
Surgery
(130)
Aged
(125)
Adult
(116)
Biological And Medical Sciences
(112)
Medical Sciences
(112)
Immunotherapy
(103)
Head And Neck Cancer
(96)
Head & Neck Cancer
(92)
Otorhinolaryngology. Stomatology
(84)
Squamous Cell Carcinoma
(82)
Head And Neck Neoplasms - Pathology
(81)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(77)
Head & Neck
(72)
Otolaryngology-Head And Neck Surgery
(45)
Oral Oncology
(43)
Clinical Cancer Research
(42)
Journal For Immunotherapy Of Cancer
(35)
Cancer Research
(33)
Cancer
(26)
The Laryngoscope
(25)
The Journal Of Immunology
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Immunology and Immunotherapy of Head and Neck Cancer

The changing therapeutic landscape of head and neck cancer

Immunotherapy for head and neck cancer: Recent advances and future directions

Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules

Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape

Head and neck cancer

Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action

Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation

Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Stage I to II Oral Cavity Cancer

PD-L1 Mediates Dysfunction in Activated PD-1 + NK Cells in Head and Neck Cancer Patients

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients

HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING

Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing

Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

American Thyroid Association statement on preoperative imaging for thyroid cancer surgery

Rising incidence of oral tongue cancer among white men and women in the United States, 1973–2012

Suchergebnisse filtern